The top 2 UK shares I would buy today
Our 6 ‘Best Buys Now’ Shares The stock market tends to slow down as Christmas approaches. Few firms announce earning results or big news, and everyone starts to wind down before the holiday. A calmer market can be the perfect time to pick up some good stocks, however. Here I consider my top two UK shares to pick up right now.What makes these my top 2 UK shares?My criteria in my choice of the top two UK shares are fairly simple. I am choosing stocks from the FTSE that I think have a balance of low risk but high potential gains. As with most of my stock picks, I look for dividends as a nice addition to any investment. With that in mind, here are my choices.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…BPThe oil giant is my first choice of UK shares to buy. BP (LSE: BP) has a nice dividend yield, despite cutting its payout earlier this year. I also think the share price itself has been under pressure that might begin to ease.The coronavirus outbreak acted as a catalyst for the oil price slump earlier in the year. The oil market does have its fundamental weaknesses that still hold true. Number one of these is the large amount of spare capacity in the market. However, with vaccines now being rolled out, the future is hopefully looking brighter.OPEC and Russia, meanwhile, will be keeping production lower in order to bolster the price of crude. While I don’t think this will be enough to see oil prices sky rocket, companies like BP don’t need them to.AstraZenecaI think AstraZeneca (LSE: AZN) could be the perfect UK share to buy this side of Christmas. Naturally, most of the press surrounding the company is dominated by its joint vaccine effort with Oxford University. While I doubt this will have any immediate positive impact on the company’s profits, it certain will help sentiment towards its shares.Given the timeline we saw with the Pfizer vaccine, I suspect January or February will see AstraZeneca’s start to roll out. I would expect its share price to bounce when this happens.The pharmaceutical giant also currently sees it share price under some pressure after it announced a $39bn acquisition of US biotech Alexion. This is a normal reaction given the payout AstraZeneca is making, but the deal will add both to its portfolio and its cash flow. Long term I think it is a good move.In addition, the likely boost all pharmaceutical firms will see with increased interest in pandemics and vaccines, likely with government support, I think makes the sector one well worth looking at.I am of the opinion that AstraZeneca is currently seeing a lower stock price than it perhaps should, making it another top pick for my choice of UK shares. Simply click below to discover how you can take advantage of this. The top 2 UK shares I would buy today Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. “This Stock Could Be Like Buying Amazon in 1997” Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! Karl Loomes | Thursday, 17th December, 2020 | More on: AZN BP Enter Your Email Address Image source: Getty Images. I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. See all posts by Karl Loomes I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Karl has shares in BP and AstraZeneca. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.